Invention Grant
- Patent Title: Compositions and their uses directed to huntingtin
-
Application No.: US13090146Application Date: 2011-04-19
-
Publication No.: US08415465B2Publication Date: 2013-04-09
- Inventor: Susan M. Freier
- Applicant: Susan M. Freier
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Isis Pharmaceuticals Patent Dept.
- Main IPC: C07H21/04
- IPC: C07H21/04

Abstract:
Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's Disease (HD) progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntington's Disease (HD) in an individual susceptible to Huntington's Disease (HD). Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
Public/Granted literature
- US20110306652A1 COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN Public/Granted day:2011-12-15
Information query